These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles. Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108 [TBL] [Abstract][Full Text] [Related]
5. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058 [TBL] [Abstract][Full Text] [Related]
6. Subcongenic analyses reveal complex interactions between distal chromosome 4 genes controlling diabetogenic B cells and CD4 T cells in nonobese diabetic mice. Stolp J; Chen YG; Cox SL; Henck V; Zhang W; Tsaih SW; Chapman H; Stearns T; Serreze DV; Silveira PA J Immunol; 2012 Aug; 189(3):1406-17. PubMed ID: 22732593 [TBL] [Abstract][Full Text] [Related]
7. Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice. Silveira PA; Chapman HD; Stolp J; Johnson E; Cox SL; Hunter K; Wicker LS; Serreze DV J Immunol; 2006 Nov; 177(10):7033-41. PubMed ID: 17082619 [TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Christianson SW; Shultz LD; Leiter EH Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606 [TBL] [Abstract][Full Text] [Related]
9. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice. Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549 [TBL] [Abstract][Full Text] [Related]
10. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model. Kachapati K; Adams DE; Wu Y; Steward CA; Rainbow DB; Wicker LS; Mittler RS; Ridgway WM J Immunol; 2012 Nov; 189(10):5001-15. PubMed ID: 23066155 [TBL] [Abstract][Full Text] [Related]
11. Congenic mapping identifies a novel Idd9 subregion regulating type 1 diabetes in NOD mice. Lin B; Ciecko AE; MacKinney E; Serreze DV; Chen YG Immunogenetics; 2017 Mar; 69(3):193-198. PubMed ID: 27796442 [TBL] [Abstract][Full Text] [Related]
12. Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells. Hamilton-Williams EE; Wong SB; Martinez X; Rainbow DB; Hunter KM; Wicker LS; Sherman LA Diabetes; 2010 Jun; 59(6):1478-86. PubMed ID: 20299469 [TBL] [Abstract][Full Text] [Related]
13. Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction. Peng J; Dicker B; Du W; Tang F; Nguyen P; Geiger T; Wong FS; Wen L J Autoimmun; 2007 Jun; 28(4):188-200. PubMed ID: 17412560 [TBL] [Abstract][Full Text] [Related]
14. Idd13 is involved in determining immunoregulatory DN T-cell number in NOD mice. Dugas V; Liston A; Hillhouse EE; Collin R; Chabot-Roy G; Pelletier AN; Beauchamp C; Hardy K; Lesage S Genes Immun; 2014 Mar; 15(2):82-7. PubMed ID: 24335706 [TBL] [Abstract][Full Text] [Related]
15. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. McAleer MA; Reifsnyder P; Palmer SM; Prochazka M; Love JM; Copeman JB; Powell EE; Rodrigues NR; Prins JB; Serreze DV Diabetes; 1995 Oct; 44(10):1186-95. PubMed ID: 7556956 [TBL] [Abstract][Full Text] [Related]
16. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice. Sgouroudis E; Albanese A; Piccirillo CA J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. Verdaguer J; Schmidt D; Amrani A; Anderson B; Averill N; Santamaria P J Exp Med; 1997 Nov; 186(10):1663-76. PubMed ID: 9362527 [TBL] [Abstract][Full Text] [Related]
18. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice. Kanagawa O; Shimizu J; Vaupel BA J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914 [TBL] [Abstract][Full Text] [Related]
19. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice. Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784 [TBL] [Abstract][Full Text] [Related]
20. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice. Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]